Picture [iito] Made Without Love 650x80px
Organisation › Details

Disc Medicine (US)

Disc Medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis) in hematologic diseases. Focused on the hepcidin pathway, the master regulator of iron metabolism, Disc is advancing first-in-class therapies to transform the treatment of hematologic diseases. *


Period Start 2017-01-01 established
Products Industry BIOTECH
  Industry 2 hematology
Persons Person Nicholson, Donald (Don) (Disc Medicine 201910– Executive Chairman before CEO of Nimbus Therapeutics)
  Person 2 Bitterman, Kevin (Atlas Venture 2017– Partner before Polaris Partners since 2004)
Region Region Cambridge, MA
  Country United States (USA)
  Street 300 Technology Square
  City 02139 Cambridge, MA
    Address record changed: 2021-02-13
Basic data Employees n. a.
    * Document for �About Section�: Disc Medicine. (10/29/19). "Press Release: Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production". Cambridge, MA.
Record changed: 2019-10-30


Picture [iito] Made Without Love 650x80px

More documents for Disc Medicine (US)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Global Partnering Four Events One Price 650x80

» top